Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AML' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 930 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Foss, B; Ulvestad, E; Hervig, T; Bruserud, O
      Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance inacute myelogenous leukemia

      INTERNATIONAL JOURNAL OF CANCER
    2. Grimwade, D
      The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Hall, GW
      Childhood myeloid leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Swirsky, DM; Richards, SJ
      Laboratory diagnosis of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    5. Lowenberg, B
      Prognostic factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    6. Dann, EJ; Rowe, JM
      Biology and therapy of secondary leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    9. Milligan, DW
      The diagnosis and management of acute myeloid leukaemia

      CLINICAL MEDICINE
    10. Mhawech, P; Buffone, GJ; Khan, SP; Gresik, MV
      Cytochemical staining and flow cytometry methods applied to the diagnosis of acute leukemia in the pediatric population: An assessment of relative usefulness

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    11. Krauter, J; Hoellge, W; Wattjes, MP; Nagel, S; Heidenreich, O; Bunjes, D; Ganser, A; Heil, G
      Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR

      GENES CHROMOSOMES & CANCER
    12. Laczika, K; Mitterbauer, G; Mitterbauer, M; Knobl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
      Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions

      LEUKEMIA & LYMPHOMA
    13. Tschan, MP; Vonlanthen, S; Cajot, JF; Peters, UR; Oppliger, E; Betticher, DC; Yarbrough, WG; Fey, MF; Tobler, A
      Different p16(INK4a) and p14(ARF) expression patterns in acute myeloid leukaemia and normal blood leukocytes

      LEUKEMIA & LYMPHOMA
    14. Watanabe, J; Kondo, H; Iwazaki, H; Hatake, K; Horikoshi, N
      An unusual association of monoclonal gammopathy, paroxysmal nocturnal haemoglobinuria and myelodysplastic syndrome transformed into acute myeloid leukaemia: Coexistence of triple clonal disorders

      LEUKEMIA & LYMPHOMA
    15. Mori, M; Hatake, K; Tanaka, M; Takatoku, M; Matsumoto, Y; Uchida, M; Kametaka, N; Nagai, T; Terui, Y; Tomizuka, H; Muroi, K; Ozawa, K
      CAM-cytarabine, aclarubicin plus macrophage colony-stimulating factor in the treatment of acute myelogenous leukemia with trilineage dysplasia: Usefulness of in vitro apoptosis in leukemic cells

      LEUKEMIA & LYMPHOMA
    16. Tohda, S; Nara, N
      Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells

      LEUKEMIA & LYMPHOMA
    17. Verstovsek, S; Estey, E; Manshouri, T; Keating, M; Kantarjian, H; Giles, FJ; Albitar, M
      High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome

      LEUKEMIA & LYMPHOMA
    18. Giles, FJ; Shen, Y; Kantarjian, HM; Korbling, MJ; O'Brien, S; Anderlini, P; Donato, M; Pierce, S; Keating, MJ; Freireich, EJ; Estey, E
      Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival

      LEUKEMIA & LYMPHOMA
    19. Dunussi-Joannopoulos, K; Leonard, JP
      Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia

      LEUKEMIA & LYMPHOMA
    20. Rosenfeld, C; Kantarjian, H
      Is myelodysplastic related acute myelogenous leukemia a distinct entity from de novo acute myelogenous leukemia? Potential for targeted therapies

      LEUKEMIA & LYMPHOMA
    21. Astrom, M; Bodin, L; Tidefelt, U
      Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population

      LEUKEMIA & LYMPHOMA
    22. Graf, J; Merk, B; Maurer, U; Muller, E; Bergmann, L
      Identification of novel polymorphisms in intron 7 of the human p53 gene inacute myeloid leukemia and healthy donors

      LEUKEMIA & LYMPHOMA
    23. Preisler, HD; Venugopal, P; Gregory, SA; Adler, S; Gezer, S; Hsu, WT; Manson, S; Larson, A; Jajeh, A; Slvinick, D; Galvez, A
      High remission rate in acute myeloblastic leukemia with only two days of chemotherapy

      LEUKEMIA & LYMPHOMA
    24. Minden, MD; Dimitroulakos, J; Nohynek, D; Penn, LZ
      Lovastatin induced control of blast cell growth in an elderly patient withacute myeloblastic leukemia

      LEUKEMIA & LYMPHOMA
    25. Montefusco, E; Fazi, F; Cordone, I; Ariola, C; Nanni, M; Spadea, A; Spiriti, MAA; Fenu, S; Mandelli, F; Petti, MC
      Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma

      LEUKEMIA & LYMPHOMA
    26. Clavio, M; Gatto, S; Beltrami, G; Cerri, R; Carrara, P; Pierri, I; Canepa, L; Miglino, M; Balleari, E; Masoudi, B; Damasio, E; Ghio, R; Sessarego, M; Gobbi, M
      First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    27. Ryoo, ZY; Kim, MO; Kim, KE; Bahk, YY; Lee, JW; Park, SH; Kim, JH; Byun, SJ; Hwang, HY; Youn, J; Kim, TY
      Expression of recombinant human granulocyte macrophage-colony stimulating factor (hGM-CSF) in mouse urine

      TRANSGENIC RESEARCH
    28. Cuenco, GM; Ren, RB
      Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

      ONCOGENE
    29. Wedding, U; Hoffken, K
      Therapy of acute myeloid leukemia in elderly patients

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    30. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
      Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias

      ANNALS OF HEMATOLOGY
    31. Castagnola, C; Alessandrino, EP; Lunghi, M; Bernasconi, P; Della Porta, M; Mangiacavalli, S; Colombo, A; Corso, A; Pagnucco, G; Lazzarino, M; Bernasconi, C
      Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience

      ANNALS OF HEMATOLOGY
    32. Sperr, WR; Wimazal, F; Kundi, M; Fonatsch, C; Thalhammer-Scherrer, R; Schernthaner, GH; Schwarzinger, I; Haas, OA; Geissler, K; Lechner, K; Valent, P
      Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems

      ANNALS OF HEMATOLOGY
    33. Ferrari, T; Weber, B; Pils, S; Harbott, J; Borkhardt, A
      Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7

      ANNALS OF HEMATOLOGY
    34. Yilmaz, A; Kaufmann, CC; Binder, C; Wormann, B; Haase, D
      Effects of amifostine in a patient with an advanced-stage myelodysplastic syndrome

      ANNALS OF HEMATOLOGY
    35. Shimohakamada, Y; Shinohara, K; Fukuda, N
      Remission of acute myeloblastic leukemia after severe pneumonia treated with high-dose methylprednisolone

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    36. Parker, JE; Mufti, GJ
      The role of apoptosis in the pathogenesis of the myelodysplastic syndromes

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    37. Kuriyama, K; Tomonaga, M; Kobayashi, T; Takeuchi, J; Ohshima, T; Furusawa, S; Saitoh, K; Ohno, R
      Morphological diagnoses of the Japan Adult Leukemia Study Group acute myeloid leukemia protocols: Central review

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    38. Hirose, Y; Masaki, Y; Shimoyama, K; Sugai, S; Nojima, T
      Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years

      EUROPEAN JOURNAL OF HAEMATOLOGY
    39. Norgaard, JM; Langkjer, ST; Palshof, T; Pedersen, B; Hokland, P
      Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    40. Kratz, CP; Emerling, BM; Donovan, S; Laig-Webster, M; Taylor, BR; Thompson, P; Jensen, S; Banerjee, A; Bonifas, J; Makalowski, W; Green, ED; Le Beau, MM; Shannon, KM
      Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies

      GENOMICS
    41. Xia, Z; Tan, MM; Wong, WWL; Dimitroulakos, J; Minden, MD; Penn, LZ
      Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

      LEUKEMIA
    42. Koistinen, P; Siitonen, T; Mantymaa, P; Saily, M; Kinnula, V; Savolainen, ER; Soini, Y
      Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system

      LEUKEMIA
    43. Raspadori, D; Damiani, D; Lenoci, M; Rondelli, F; Testoni, N; Nardi, G; Sestigiani, C; Mariotti, C; Birtolo, S; Tozzi, M; Lauria, F
      CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

      LEUKEMIA
    44. Verstovsek, S; Kantarjian, H; Estey, E; Aguayo, A; Giles, FJ; Manshouri, T; Koller, C; Estrov, Z; Freireich, E; Keating, M; Albitar, M
      Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

      LEUKEMIA
    45. Rombouts, WJC; Lowenberg, B; van Putten, WLJ; Ploemacher, RE
      Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene

      LEUKEMIA
    46. Marcucci, G; Caligiuri, MA; Dohner, H; Archer, KJ; Schlenk, RF; Dohner, K; Maghraby, EA; Bloomfield, CD
      Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia

      LEUKEMIA
    47. Jones, LK; Chaplin, T; Shankar, A; Neat, M; Patel, N; Samuel, DP; Hill, AS; Debernardi, S; Bassini, A; Young, BD; Saha, V
      Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia

      LEUKEMIA
    48. Koschmieder, S; Hofmann, WK; Kunert, J; Wagner, S; Ballas, K; Seipelt, G; Hoelzer, D; Ottmann, OG; Kalina, U
      TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34(+) cells from healthy donors, but not from patients with AML after MDS

      LEUKEMIA
    49. Lezon-Geyda, K; Najfeld, V; Johnson, EM
      Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndromeand progression to acute myelogenous leukemia

      LEUKEMIA
    50. Minelli, A; Morerio, C; Maserati, E; Olivieri, C; Panarello, C; Bonvini, L; Leszl, A; Rosanda, C; Lanino, E; Danesino, C; Pasquali, F
      Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia

      LEUKEMIA
    51. Oomen, SPMA; Lichtenauer-Kaligis, EGR; Verplanke, N; Hofland, J; Lamberts, SWJ; Lowenberg, B; Touw, IP
      Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2

      LEUKEMIA
    52. Karp, JE
      MDR modulation in acute myelogenous leukemia: is it dead?

      LEUKEMIA
    53. Creutzig, U; Ritter, J; Zimmermann, M; Hermann, J; Gadner, H; Sawatzki, DB; Niemeyer, CM; Schwabe, D; Selle, B; Boos, J; Kuhl, J; Feldges, A
      Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93

      LEUKEMIA
    54. Jahns-Streubel, G; Braess, J; Schoch, C; Fonatsch, C; Haase, D; Binder, C; Wormann, B; Buchner, T; Hiddemann, W
      Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF

      LEUKEMIA
    55. van den Heuvel-Eibrink, MM; Wiemer, EAC; de Boevere, MJ; Slater, RM; Smit, EME; van Noesel, MM; van der Holt, B; Schoester, M; Pieters, R; Sonneveld, P
      MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7

      LEUKEMIA
    56. Woiciechowsky, A; Regn, S; Kolb, HJ; Roskrow, M
      Leukemic dendritic cells generated in the presence of FLT3 ligand have thecapacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

      LEUKEMIA
    57. Chambost, H; van Baren, N; Brasseur, F; Olive, D
      MAGE-A genes are not expressed in human leukemias

      LEUKEMIA
    58. van der Kolk, DM; de Vries, EGE; Noordhoek, L; van den Berg, E; van der Pol, MA; Muller, M; Vellenga, E
      Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia

      LEUKEMIA
    59. Leung, W; Ribeiro, RC; Hudson, M; Tong, X; Srivastava, DK; Rubnitz, JE; Sandlund, IT; Razzouk, BI; Evans, WE; Pui, CH
      Second malignancy after treatment of childhood acute myeloid leukemia

      LEUKEMIA
    60. Sarriera, JE; Albitar, M; Estrov, Z; Gidel, C; Aboul-Nasr, R; Manshouri, T; Kornblau, S; Chang, KS; Kantarjian, H; Estey, E
      Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing

      LEUKEMIA
    61. Perambakam, S; Li, BR; Preisler, H
      Quantitation of interferon regulatory factor transcripts in patients with acute myeloid leukemia

      CANCER INVESTIGATION
    62. Mrozek, K; Prior, TW; Edwards, C; Marcucci, G; Carroll, AJ; Snyder, PJ; Koduru, PRK; Theil, KS; Pettenati, MJ; Archer, KJ; Caligiuri, MA; Vardiman, JW; Kolitz, JE; Larson, RA; Bloomfield, CD
      Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study

      JOURNAL OF CLINICAL ONCOLOGY
    63. Krance, RA; Hurwitz, CA; Head, DR; Raimondi, SC; Behm, FG; Crews, KR; Srivastava, DK; Mahmoud, H; Roberts, WM; Tong, X; Blakley, RL; Ribeiro, RC
      Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

      JOURNAL OF CLINICAL ONCOLOGY
    64. Creutzig, U; Ritter, J; Zimmermann, M; Reinhardt, D; Hermann, J; Berthold, F; Henze, G; Jurgens, H; Kabisch, H; Havers, W; Reiter, A; Kluba, U; Niggli, F; Gadner, H
      Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93

      JOURNAL OF CLINICAL ONCOLOGY
    65. Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, I; Canepa, L; Miglino, M; Muner, P; Damasio, E; Gobbi, M
      Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    66. Bahia, DMM; Yamamoto, M; Chauffaille, MDLF; Kimura, EYS; Bordin, JO; Filgueiras, MAC; Kerbauy, J
      Aberrant phenotypes in acute myeloid leukemia: a high frequency and clinical significance

      HAEMATOLOGICA
    67. Schaich, M; Illmer, T; Seitz, G; Mohr, B; Schakel, U; Beck, JF; Ehninger, G
      The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia

      HAEMATOLOGICA
    68. Bernasconi, P; Calatroni, S; Boni, M; Cavigliano, PM; Pagnucco, G; Bernasconi, C
      p230 does not always predict a mild clinical course in myeloid malignancies: e19a2 bcr/abl fusion transcript with additional chromosome abnormalitiesin a patient with acute monoblastic leukemia (M5a)

      HAEMATOLOGICA
    69. Chillon, MC; Garcia-Sanz, R; Balanzategui, A; Ramos, F; Fernandez-Calvo, J; Rodriguez, MJ; Rodriguez-Salazar, MI; Corrales, A; Calmuntia, MJ; Orfao, A; Gonzalez, M; San Miguel, JF
      Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain

      HAEMATOLOGICA
    70. Wieser, R; Schreiner, U; Wollenberg, B; Neubauer, A; Fonatsch, C; Rieder, H
      Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia

      HAEMATOLOGICA
    71. Lima, M; Orfao, A; Coutinho, J; Ferreiro, G; Freitas, I; Silvestre, F; Justica, B
      An unusual acute myeloid leukemia associated with hyper IgE: another case of AML-M5c?

      HAEMATOLOGICA
    72. Suarez, L; Vidriales, MB; Garcia-Larana, J; Lopez, A; Martinez, R; Martin-Reina, V; Tormo, M; Gonzalez-San Miguel, JD; Lavilla, E; Garcia-Boyero, R; Orfao, A; San Miguel, JF
      Multiparametric analysis of apoptotic and multidrug resistance phenotypes according to the blast cell maturation stage in elderly patients with acutemyeloid leukemia

      HAEMATOLOGICA
    73. Lindvall, C; Nordenskjold, M; Porwit, A; Bjorkholm, M; Blennow, E
      Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements

      HAEMATOLOGICA
    74. Leoni, F; Ciolli, S; Nozzoli, C; Santini, V; Fanci, R; Ferrini, PR
      Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report

      HAEMATOLOGICA
    75. Paredes-Aguilera, R; Romero-Guzman, L; Lopez-Santiago, N; Burbano-Ceron, L; Camacho-Del Monte, O; Nieto-Martinez, S
      Flow cytometric analysis of cell-surface and intracellular antigens in thediagnosis of acute leukemia

      AMERICAN JOURNAL OF HEMATOLOGY
    76. Hiebert, SW; Lutterbach, B; Durst, K; Wang, LL; Linggi, B; Wu, S; Wood, L; Amann, J; King, D; Hou, Y
      Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    77. Buchner, T; Hiddemann, W; Berdel, W; Wormann, B; Loffler, H; Schoch, C; Haferlach, T; Ludwig, WD; Maschmeyer, G; Staib, P; Andreesen, R; Balleisen, L; Haase, D; Eimermacher, H; Aul, C; Rasche, H; Uhlig, J; Gruneisen, A; Reis, HE; Hartlapp, J; Hirschmann, WD; Weh, HJ; Pielken, HJ; Gassmann, W; Sauerland, MC; Heinecke, A
      Remission induction therapy: the more intensive the better?

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    78. Burnett, AK
      Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    79. Legdeur, MCJC; Broekhoven, MG; Schuurhuis, GJ; Beelen, RHJ; Ossenkoppele, GJ
      Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    80. Creutzig, U; Berthold, F; Boos, J; Fleischhack, G; Gadner, H; Gnekow, A; Graubner, U; Henze, G; Hermann, J; Imbach, P; Jurgens, H; Kabisch, H; Korholz, D; Niemeyer, CM; Reinhardt, D; Reiter, A; Ritter, J; Spaar, HJ; Zimmermann, M
      Improved treatment results in children with AML: Results of study AML-BFM 93

      KLINISCHE PADIATRIE
    81. Okamoto, Y; Tsuda, T; Matsunami, M; Hirose, T; Sakaguchi, R; Katayama, N; Ota, K
      Treatment of acute myeloblastic leukaemia in a patient with Bombay blood type: a case report

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    82. Meloni, G; Proia, A; Capria, S; Romano, A; Trape, G; Trisolini, SM; Vignetti, M; Mandelli, F
      Obesity and autologous stem cell transplantation in acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    83. Chiang, KY; Van Rhee, F; Godder, K; Bridges, K; Adams, S; Mehta, J; Henslee-Downey, PJ
      Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    84. Platzbecker, U; Thiede, C; Freiberg-Richter, J; Rollig, C; Helwig, A; Schakel, U; Mohr, B; Schaich, M; Ehninger, G; Bornhauser, M
      Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

      BONE MARROW TRANSPLANTATION
    85. Kroon, E; Thorsteinsdottir, U; Mayotte, N; Nakamura, T; Sauvageau, G
      NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acutemyeloid leukemias in mice

      EMBO JOURNAL
    86. Paulsson, K; Sall, T; Fioretos, T; Mitelman, F; Johansson, B
      The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology

      CANCER GENETICS AND CYTOGENETICS
    87. Emberger, W; Behmel, A; Tschernigg, M; Seewann, HL; Petek, E; Kroisel, PM; Wagner, K
      Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;10;22)(q34;q22;q11)

      CANCER GENETICS AND CYTOGENETICS
    88. Vieira, L; Oliveira, V; Ambrosio, AP; Marques, B; Pereira, AM; Hagemeijer, A; Boavida, MG
      Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2): a four-way variant of t(8;21)

      CANCER GENETICS AND CYTOGENETICS
    89. Schoch, C; Bursch, S; Kern, W; Schnittger, S; Hiddemann, W; Haferlach, T
      Gain of an isochromosome 5p: a new recurrent chromosome abnormality in acute monoblastic leukemia

      CANCER GENETICS AND CYTOGENETICS
    90. Devemy, E; Li, B; Tao, M; Horvath, E; Chopra, H; Fisher, L; Nayini, J; Creech, S; Venugopal, P; Yang, J; Kaspar, C; Hsu, WT; Preisler, HD
      Poor prognosis acute myelogenous leukemia: 3-biological and molecular biological changes during remission induction therapy

      LEUKEMIA RESEARCH
    91. O'Gorman, DM; McKenna, SL; McGahon, AJ; Cotter, TG
      Inhibition of PI3-kinase sensitises HL60 human leukaemia cells to both chemotherapeutic drug- and Fas-induced apoptosis by a JNK independent pathway

      LEUKEMIA RESEARCH
    92. Longley, BJ; Reguera, MJ; Ma, YS
      Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

      LEUKEMIA RESEARCH
    93. Ferrao, P; Sincock, P; Cole, S; Ashman, L
      Intracellular P-gp contributes to functional drug efflux and resistance inacute myeloid leukaemia

      LEUKEMIA RESEARCH
    94. Wimazal, F; Sperr, WR; Kundi, M; Meidlinger, P; Fonatsch, C; Jordan, JH; Thalhammer-Scherrer, R; Schwarzinger, I; Geissler, K; Lechner, K; Valent, P
      Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes

      LEUKEMIA RESEARCH
    95. Cox, MC; Panetta, P; Venditti, A; Abruzzese, E; Del Poeta, G; Cantonetti, M; Amadori, S
      New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia

      LEUKEMIA RESEARCH
    96. Inaba, T; Shimazaki, C; Sumikuma, T; Ochiai, N; Okano, A; Hatsuse, M; Ashihara, E; Kobayashi, Y; Rin, K; Murakami, S; Haruyama, H; Fujita, N; Nakagawa, M
      Clinicopathological features of myeloid/natural killer (NK) cell precursoracute leukemia

      LEUKEMIA RESEARCH
    97. Lee, JJ; Chung, IJ; Park, MR; Ryang, DW; Park, CS; Kim, HJ
      Increased angiogenesis and Fas-ligand expression are independent processesin acute myeloid leukemia

      LEUKEMIA RESEARCH
    98. Koistinen, P; Siitonen, T; Mantymaa, P; Savolainen, ER
      p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death

      LEUKEMIA RESEARCH
    99. Ohyashiki, K; Nishimaki, J; Shoji, N; Miyazawa, K; Kimura, Y; Ohyashiki, JH
      Re-evaluation of refractory anemia with excess blasts in transformation

      LEUKEMIA RESEARCH
    100. Kilian, PH; Skrzypek, S; Becker, N; Havemann, K
      Exposure to armament wastes and leukemia: a case-control study within a cluster of AML and CML in Germany

      LEUKEMIA RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 01:45:11